Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal NOD1 Primary Antibody for IHC, IHC (p) - ABIN4340241
Swaan, Bensman, Bahadduri, Hall, Sarkar, Bao, Khantwal, Ekins, Knoell: Bacterial peptide recognition and immune activation facilitated by human peptide transporter PEPT2. in American journal of respiratory cell and molecular biology 2008
Show all 2 Pubmed References
Human Polyclonal NOD1 Primary Antibody for IHC (fro), IHC (p) - ABIN537419
Necchi, Sommi, Vanoli, Manca, Ricci, Solcia: Proteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study. in PLoS ONE 2011
Human Polyclonal NOD1 Primary Antibody for IF (p), IHC (p) - ABIN872332
Arentsen, Qian, Gkotzis, Femenia, Wang, Udekwu, Forssberg, Diaz Heijtz: The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. in Molecular psychiatry 2016
Human Polyclonal NOD1 Primary Antibody for ELISA, FACS - ABIN4340244
Hosokawa, Hirao, Yumoto, Washio, Nakanishi, Takegawa, Kitamura, Matsuo: Functional Roles of NOD1 in Odontoblasts on Dental Pulp Innate Immunity. in BioMed research international 2016
Human Polyclonal NOD1 Primary Antibody for IHC (p), WB - ABIN4340243
Scott, Chen, Sun, Billiar: Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine production. in Journal of hepatology 2010
Human Polyclonal NOD1 Primary Antibody for ELISA, WB - ABIN4235349
Lu, Zou, Feng, Yuan, Gu, Li, Li, Jin, Li: Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis. in World journal of gastroenterology 2010
Human Polyclonal NOD1 Primary Antibody for WB - ABIN1169390
Costello, Joyce, Abrahams: NOD protein expression and function in first trimester trophoblast cells. in American journal of reproductive immunology (New York, N.Y. : 1989) 2006
In transgenic mice expressing human NOD1 and deficient for the murine NOD1, we showed enhanced clearance of a lipl21- mutant of Leptospira interrogans compared to the complemented strain, or to what was observed in NOD1KO mice, suggesting that LipL21 facilitates escape from immune surveillance in humans.
A role for NOD1 in HCMV control via RIPK2 (show RIPK2 Antibodies)- IKKalpha (show CHUK Antibodies)-IRF3 (show IRF3 Antibodies) signaling, NOD1 polymorphisms predict the risk of infection.
Bronchial epithelial overexpression of TLR4 (show TLR4 Antibodies) and NOD1 in severe/very severe stable COPD (show ARCN1 Antibodies), associated with increased bronchial inflammation and P. aeruginosa bacterial load, may play a role in the pathogenesis of COPD (show ARCN1 Antibodies)
study provides structural and dynamic insights into the NOD1-RIP2 (show ARHGEF28 Antibodies) oligomer formation, which will be crucial in understanding the molecular basis of NOD1-mediated CARD-CARD interaction in higher and lower eukaryotes
Nucleotide-binding oligomerization domain (NOD1) was the most significantly associated gene when analyzing exonic rare variants (RVs) in chromosome 7p to carotid bifurcation intima-media thickness (bIMT).
Fusion of human SGT1 (show SUGT1 Antibodies) (hSGT1 (show ECD Antibodies)) to NOD1 LRR significantly enhanced the solubility, and the fusion protein was stabilized by coexpression of mouse Hsp90alpha (show HSP90AA2 Antibodies).
the results suggest that the chronic activation of NOD1 and NOD2 (show NOD2 Antibodies) receptors might play a role in the development of gastric cancer.
this study reveals that LRRK2 is a new positive regulator of Rip2 (show ARHGEF28 Antibodies) and promotes inflammatory cytokine induction through the Nod1/2-Rip2 (show ARHGEF28 Antibodies) pathway.
Finally, NOD1 agonist increased the formation of cranial and subintestinal vessel plexus in zebrafish, and this effect was abrogated by concurrent PPARgamma (show PPARG Antibodies) activation. Overall, these findings identify a PPARgamma (show PPARG Antibodies)-miR (show MLXIP Antibodies)-125a-NOD1 signaling axis in endothelial cells that is critical in the regulation of inflammation-mediated angiogenesis.
NOD1/2 gene variants are not linked with T2DM and IR.
These findings reveal macrophage NOD1 as a cell-specific target to combat diet-induced inflammation past the step of macrophage infiltration, leading to insulin (show INS Antibodies) resistance.
The studies establish chronic pancreatitis as an IL-33 (show IL33 Antibodies)-dependent inflammation resulting from synergistic interactions between the NOD1 and CCKR signaling pathways.
Results show that the simultaneous absence of Nod1 and Nod2 (show NOD2 Antibodies) is associated with accelerated T cell death upon alloantigen encounter, suggesting these proteins might provide new targets to ameliorate T cell responses in a variety of inflammatory states, including those associated with bone marrow or solid organ transplantation.
this study shows that the effect of the gut (show GUSB Antibodies) microbiota on bone is dependent on NOD1 and NOD2 (show NOD2 Antibodies) signaling
we propose that NOD1 signaling in mesenchymal stromal cells serves as an important pathway underlying the requirement for microbiota in the maintenance of steady-state hematopoiesis
results suggest a previously unappreciated role for the innate immune receptor Nod1 in suppressing colitis-associated tumorigenesis through a T cell-mediated mechanism
NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes.
this study reveals that LRRK2 is a new positive regulator of Rip2 (show ARHGDIG Antibodies) and promotes inflammatory cytokine induction through the Nod1/2-Rip2 (show ARHGDIG Antibodies) pathway.
this paper shows that deletion of NOD1 aggravated bone resorption induced by Gram-negative bacteria, accompanied by an increase in the numbers of osteoclasts
Sertoli cells have a functional NALP3 (show NLRP3 Antibodies) inflammasome that modulates NOD1 and pro-IL-1beta (show IL1B Antibodies) expression, while NOD2 (show NOD2 Antibodies) inversely promoted IL-1beta (show IL1B Antibodies) expression.
This gene encodes a member of the NOD (nucleotide-binding oligomerization domain) family. This member is a cytosolic protein. It contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. Multiple alternatively spliced transcript variants differring in the 5' UTR have been described, but the full-length nature of these variants has not been determined.
NLR family, CARD domain containing 1
, caspase recruitment domain family, member 4
, caspase recruitment domain-containing protein 4
, nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 1
, nucleotide-binding oligomerization domain-containing protein 1
, caspase recruitment domain 4